Energy-Saving Summary

• Solve joined 157 other organizations in urging Congress to work toward the enactment of the fiscal year (FY) 2026 Defense Appropriations Act, to ensure full funding levels for the Defense Health Research Programs, including the Congressionally Directed Medical Research Programs (CDMRP). Read the sign-on letter here.
  
  

• Solve was recently featured in International Business Times, highlighting our leadership and mission to reframe the national response to ME/CFS and Long Covid. Read the article here.
  
  
  
• Help us move science forward with a gift today. All donations made to Solve through December 31st will be matched up to $321,000!

Solve Urges Congress to Pass the FY2026 Defense Appropriations Act
 

As part of our ongoing coalition work, Solve M.E. joined over 157 organizations in urging Congress to pass a fully funded FY2026 Defense Appropriations Act. This annual bill includes the Congressionally Directed Medical Research Programs (CDMRP), a critical source of funding for scientific research on infection-associated and chronic diseases like ME/CFS and Long COVID. Without final appropriations, these programs are at risk of devastating cuts -- just as we saw earlier this year under a long-term continuing resolution that slashed CDMRP funding by 57%.

We are working alongside the Defense Health Research Consortium (DHRC) to advocate directly to House and Senate leadership. Delays in passing this bill not only stall life-saving research but also harm scientific progress and disrupt the workforce behind medical innovation. We’ll continue pushing for bipartisan action to protect CDMRP and ensure research funding is restored and expanded.

Read the letter to Congress here. 

International Business Times Spotlights Solve's Leadership and Mission

We’re pleased to share that International Business Times recently profiled Solve, highlighting our urgent mission to reframe the national response to ME/CFS and Long Covid. The feature explores the challenges millions continue to face, the gaps in research and medical understanding, and how Solve is working to accelerate scientific progress and elevate the voices of patients who have been ignored for far too long.

Read the article here.

This kind of national media visibility is invaluable—it broadens awareness, brings new supporters into the conversation, and reinforces the importance of sustained investment in research and advocacy. We’re grateful to see Solve’s work recognized on a global platform. 

As we continue pushing for scientific breakthroughs, your support remains essential.

Please make a gift to Solve today to help us move science forward and build the future patients deserve. All gifts made through December 31st will be matched up to $321,000!